The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'January, 2019'. If you still can't find what you are looking for, try using the search box.
We are delighted to announce the release of the January edition of the OBN Monthly Newsletter.
Aurelia Bioscience, a UK based CRO announces new Kinase Compound Profiling services using Promega’s NanoBRET™ technology.
Read the rest of entry »
Isansys Lifecare is proud to announce it has been selected as one of the top four finalists for the Gore Technology Innovation Center Prize for its world-leading wireless patient monitoring technology.
Take a look at the interview of Mike Karim, CEO of Oxford Endovascular outlining the state of development of its ‘origami’ flow diverter for treatment of intracranial aneurysms and its future plans at the JP Morgan conference in January.
The University of Birmingham and University Hospitals Birmingham NHS Foundation Trust (UHB) have launched a new study funded by The Drake Foundation to review and potentially enhance concussion diagnosis in Premier League football.
Abingdon, UK, 22 January 2019: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, is delighted to announce the success of their 2nd annual BioSeed® event held on Wednesday,16 January 2019, at Level 39 in Canary Wharf, London.
AMSBIO has added new experimental cell lines to its CAR T cell research range.
Recent FDA approval of CAR T cells for treatment of leukemia and lymphoma has resulted in rapid growth in research on the therapeutic uses of such cells. The new AMSBIO experimental cell lines provide you with the power to screen antibodies and ligands against your target, enhancing your search for new CAR T therapies.
Oxford, UK, January 17, 2019. Absolute Antibody Ltd., an industry-leading manufacturer of recombinant antibodies, announces its manufacturing facility based in Wilton Centre, Redcar, England has been certified under ISO 9001:2015 as of December 17, 2018.
Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that Bahija Jallal has been appointed as Chief Executive Officer and Director of the Board.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.